¹The rational use of drugs: report of the conference of experts, Nairobi, Kenya, November 1985. Geneva: WHO.

² World Health Assembly resolution entitled “The rational use of drugs”, WHA41.16, May 1988.

³Thirty-first Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations, Technical Report Series 790. Geneva: WHO, 1990.

⁴Counterfeit drugs: report of a joint WHO/IFPMA workshop, 1-3 April 1992. Geneva: WHO.

⁵ Summary of WHO counterfeit drug database as of April 1999, unpublished paper of the WHO Division of Drug Management and Policies. Geneva: WHO, 1999.

⁶Black’s law dictionary, 5th ed. St. Paul, MN: West Publishing Co., 1979.

⁷Pharmaceutical counterfeiting and anti-counterfeiting measures, Scrip Reports, PJB Publications Ltd., October 1993.

⁸ The Federal Food, Drug and Cosmetic Act, Subchapter II: reproduced in the United States Pharmacopoeia, USP23, 1995, United States Pharmacopoeial Convention, Inc., Rockville, MD.

⁹Pakistan manual of drug laws. Lahore: Lahore Times Publication, 1987.

¹⁰ Republic Act No. 8203, Republic of the Philippines, Congress of the Philippines, 22 July 1996.

¹¹Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations, Technical Report Series 863. Geneva: WHO, 1996.

¹² Summary of WHO counterfeit drug database as of April 1999, unpublished paper of the WHO Division of Drug Management and Policies. Geneva: WHO, 1999.

¹³ Summary of WHO counterfeit drug database as of April 1999, unpublished paper of the WHO Division of Drug Management and Policies. Geneva: WHO, 1999.

¹⁴ Counterfeit drug information: summary of returned questionnaire for country file, unpublished paper of the WHO Division of Drug Management and Policies. Geneva: WHO, 1997.

¹⁵ Wong Yip Lung, Mission report: Lao People’s Democratic Republic. WHO Regional Office for the Western Pacific, 5 September 1994.

¹⁶Mission report: Lao People’s Democratic Republic. WHO Regional Office for the Western Pacific, 17 April 1995.

¹⁷ Takako Mura, Mission report: Socialist Republic of Viet Nam. WHO Regional Office for the Western Pacific, 25 September 1992.

¹⁸ Trinh Van Lau, Country experience: Viet Nam, reproduced in the report of the Workshop on Providing Quality Medicines for Health Care, International Federation of Pharmaceutical Associations, Bangkok, Thailand, 6-8 December 1995.

¹⁹ Trinh Van Quy, in reply to the survey questionnaire for the country study on problems of counterfeit drugs, 1995.

²⁰ La Qualité des médicaments sur le marché pharmaceutique africain: étude analytique dans trois pays; Cameroun, Madgascar, Tchad. Action Programme on Essential Drugs, WHO/DAP 95.3. Geneva: WHO, 1995.

²¹ Unpublished report of Project Philcap, April 1995.